Callan Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $218K | Sell |
344
-68
| -17% | -$43.1K | 0.02% | 337 |
|
|
2024
Q4 | $293K | Buy |
412
+49
| +13% | +$34.9K | 0.02% | 258 |
|
|
2024
Q3 | $382K | Buy |
363
+39
| +12% | +$41K | 0.03% | 222 |
|
|
2024
Q2 | $341K | Buy |
324
+21
| +7% | +$22.1K | 0.03% | 216 |
|
|
2024
Q1 | $292K | Buy |
+303
| New | +$292K | 0.03% | 212 |
|